List of Oncology Medication For

Gastrointestinal

The gastrointestinal system includes the mouth, pharynx (throat), esophagus, stomach, small intestine, large intestine, rectum, and anus. It also includes the salivary glands, liver, gallbladder, and pancreas, which make digestive juices and enzymes that help the body digest food and liquids.

Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection

Kidney, Chronic Disease, Colon, Esophageal, Gastrointestinal, Head And Neck, Lung Cancer, Solid Tumors, Urothelial Carcinoma

Brand Name: Opdivo Qvantig. Generic Name: (nivolumab and hyaluronidase-nvhy). It is used to treat Renal Cell Carcinoma (RCC), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN), Urothelial Carcinoma (UC), Colorectal Cancer, Hepatocellular Carcinoma (HCC), Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma..

OPDIVO QVANTIG is a combination of nivolumab, a programmed death receptor-1 (PD-1)-blocking antibody, and hyaluronidase, an endoglycosidase, indicated for the treatment of Renal Cell Carcinoma (RCC), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN), Urothelial Carcinoma (UC), Colorectal Cancer, Hepatocellular Carcinoma (HCC), Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma.

Brand Name:	Opdivo Qvantig
Generic Name:	nivolumab and hyaluronidase-nvhy
Strength:	• Injection: 600 mg nivolumab and 10,000 units hyaluronidase per 5 mL (120 mg/2,000 units per mL) in a single-dose vial.
Manufacturer:	Bristol-Myers Squibb
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Pembrolizumab Injection

Kidney, Breast Cancer, Gastrointestinal, Lung Cancer, Lymphoma, Skin

Brand Name: Keytruda. Generic Name: pembrolizumab
Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

Facts about pembrolizumab injection

USAGE-intravenous
MEDICINE APPROVED BY- European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Initial U.S. Approval: 2014
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “pembrolizumab injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

pimitespib tablets

Gastrointestinal

pimitespib tablets

Jeselhy (pimitespib) inhibits HSP90, thereby showing an antitumor effect by destabilizing and reducing proteins such as KIT, PDGFRA, HER2, and EGFR which are involved in the growth and survival of cancer. It is indicated for the treatment of gastrointestinal stromal tumors (GIST) that have progressed after chemotherapy. Jeselhy has been approved by the PMDA in Japan in June 2022.

Facts about pimitespib-tablets

DISEASE INDICATIONS-Gastric Cancer
MANUFACTURER-Taiho Pharmaceuticals
USAGE-Oral
MEDICINE APPROVED BY-Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “sotorasib tablets” based on the information you provide.

QINLOCK (ripretinib) tablets

Gastrointestinal

QINLOCK (ripretinib) – GIST therapy in India

QINLOCK is a kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.

Brand Name:	QINLOCK
Generic Name:	ripretinib
Strength:	• Tablets: 50 mg
Manufacturer:	Deciphera Pharmaceuticals, LLC,
Approved By:	EMA, USFDA

Source Details: Patient Information
QINLOCK must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access QINLOCK for gastrointestinal stromal tumor treatment on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to QINLOCK (ripretinib) for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

Ramucirumab Injection

Gastrointestinal, Lung Cancer

ramucirumab injection,
for intravenous use Initial U.S. Approval: 2014

Cyramza (ramucirumab) is a medication used for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma, metastatic non small cell lung cancer, and metastatic colorectal cancer.

This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.

Facts about ramucirumab injection

Disease Indications-Colorectal Cancer, Gastric Cancer, Lung Cancer
Manufacturer-Lilly
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ramucirumab injection” based on the information you provide.

Regorafenib Tablets

Colon

regorafenib tablets,
oral Initial U.S. Approval: 2012

Stivarga is a medicine used to treat colon or rectal cancer (CRC), gastrointestinal stromal tumor (GIST), and hepatocellular carcinoma (HCC).

Facts about regorafenib tablets

Disease Indications-Colorectal Cancer
Manufacturer-Bayer
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “regorafenib tablets” based on the information you provide.

REZDIFFRA (resmetirom) tablets

Liver, Gastrointestinal

REZDIFFRA (resmetirom) – MASH, formerly NASH Therapy in India

Rezdiffra (resmetirom) is the first FDA-approved medication for adults with metabolic dysfunction-associated steatohepatitis (MASH, formerly NASH) who have moderate to advanced liver scarring (fibrosis), used alongside diet and exercise to reduce liver fat, inflammation, and scarring by targeting liver thyroid hormone receptors. It’s an oral tablet taken once daily and works as a liver-directed therapy, though potential side effects include diarrhea, nausea, itching, and gallbladder issues, with ongoing studies confirming its long-term benefits.

Brand Name:	REZDIFFRA
Generic Name:	Resmetirom Tablets
Strength:	• Tablets: 60 mg, 80 mg, and 100 mg
Manufacturer:	Madrigal Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information.
REZDIFFRA must always be used under the supervision of a Registered Medical Practitioner (RMP).

Access REZDIFFRA for MASH, formerly NASH on a Named Patient Import Basis

IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to REZDIFFRA (resmetirom) tablets for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).

Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.

REZDIFFRA (resmetirom) tablets

Liver

REZDIFFRA (resmetirom) tablets, for oral use Initial U.S. Approval: 2024

REZDIFFRA (resmetirom) is used to treat a certain liver disease (nonalcoholic steatohepatitis-NASH). In people with NASH, fat builds up in the liver leading to inflammation and more serious liver problems over time. Resmetirom works by decreasing the buildup of fat in the liver and may help prevent further liver damage.

Brand Name:	REZDIFFRA
Generic Name:	resmetirom
Strength:	Tablets: 60 mg, 80 mg, and 100 mg
Manufacturer:	Madrigal Pharmaceuticals
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “REZDIFFRA (resmetirom) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for REZDIFFRA (resmetirom) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Ripretinib Tablets

Gastrointestinal

ripretinib tablets,
for oral use Initial U.S. Approval: 2020

Qinlock is a medication used for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST), who have received different types of treatment with 3 or more kinase inhibitors, including imatinib, sunitinib and regorafenib.

Facts about ripretinib tablets

Disease Indications-Gastric Cancer
Manufacturer-Deciphera Pharmaceuticals, Inc.
Usage-Oral
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ripretinib tablets” based on the information you provide.

Sacituzumab Govitecan-HZIY for Injection

Breast Cancer, Gastrointestinal

Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

Sacituzumab govitecan-hziy for injection is a “used to treat Urothelial Carcinoma, Breast Cancer“. TRODELVY for injection is a “prescription medicine. It is available in “form and strength” For injection: 180 mg lyophilized powder in single-dose vials for reconstitution.. TRODELVY for injection can be obtained in India upon request.

Facts about your medicine

Name: TRODELVY
Active substance: sacituzumab govitecan-hziy
Disease Indications-Urothelial Carcinoma, Breast Cancer
Manufacturer-Immunomedics Inc.
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here for TRODELVY usage
(see Drugs@FDA for complete indication)

Access the best support services globally

IPN, New Delhi can facilitate patient to import of “sacituzumab govitecan-hziy for injection” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Gastrointestinal

Brand Name: Keytruda. Generic Name: pembrolizumab Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

Facts about pembrolizumab injection

Access the best support services globally

pimitespib tablets

Facts about pimitespib-tablets

Access the best support services globally

QINLOCK (ripretinib) – GIST therapy in India

Access QINLOCK for gastrointestinal stromal tumor treatment on a Named Patient Import Basis

ramucirumab injection, for intravenous use Initial U.S. Approval: 2014

Facts about ramucirumab injection

Access the best support services globally

regorafenib tablets, oral Initial U.S. Approval: 2012

Access the best support services globally

REZDIFFRA (resmetirom) – MASH, formerly NASH Therapy in India

Access REZDIFFRA for MASH, formerly NASH on a Named Patient Import Basis

REZDIFFRA (resmetirom) tablets, for oral use Initial U.S. Approval: 2024

ripretinib tablets, for oral use Initial U.S. Approval: 2020

Access the best support services globally

Generic Name: sacituzumab govitecan-hziy. It is used to treat adults with a type of breast cancer known as triple-negative breast cancer.

Facts about your medicine

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

Brand Name: Keytruda. Generic Name: pembrolizumab
Keytruda (pembrolizumab) is used to treat Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer

ramucirumab injection,
for intravenous use Initial U.S. Approval: 2014

regorafenib tablets,
oral Initial U.S. Approval: 2012

ripretinib tablets,
for oral use Initial U.S. Approval: 2020